Altermatt, Anna http://orcid.org/0000-0001-6397-0758
Gaetano, Laura
Magon, Stefano
Häring, Dieter A.
Tomic, Davorka
Wuerfel, Jens
Radue, Ernst-Wilhelm
Kappos, Ludwig
Sprenger, Till
Article History
Received: 10 November 2017
Accepted: 25 May 2018
First Online: 29 May 2018
Compliance with Ethical Standards
:
: Anna Altermatt: No conflicts of interest. Laura Gaetano: Temporary employee of Novartis Pharma AG. Stefano Magon: received research support from Swiss MS Society, Swiss National Science Foundation, University of Basel and Stiftung zur Förderung der gastroenterologischen und allgemeinen klinischen Forschung sowie der medizinischen Bildauswertung des Universitätsspitals Basel. Dieter Haering, Davorka Tomic: Full-time employee of Novartis Pharma AG. Jens Wuerfel: is CEO of MIAC AG. He served on advisory boards for Actelion, Biogen, Genzyme, Novartis and Roche. He received research grants from Novartis, and speaker honoraria from Bayer, Biogen, Genzyme, Novartis, Teva and Biogen. JW was supported by the DFG, the EU, the German ministry of education and research (BMBF/KKNMS) and the German ministry of economy (BMWi). Ernst-Wilhelm Radue: has received research support from Biogen Idec, Merck-Serono, Novartis and Actelion. Ludwig Kappos: Author’s institution (University Hospital Basel) has received in last 3 years and used exclusively for research support: steering committee, advisory board, and consultancy fees (Actelion, Addex, Bayer HealthCare, Biogen Idec, Biotica, Genzyme, Lilly, Merck,Mitsubishi, Novartis, Ono Pharma, Pfizer, Receptos, Sanofi, Santhera, Siemens, Teva, UCB, XenoPort); speaker fees (Bayer HealthCare, Biogen Idec, Merck, Novartis, Sanofi, Teva); support of educational activities (Bayer HealthCare, Biogen, CSL Behring, Genzyme, Merck, Novartis, Sanofi, Teva); royalties (Neurostatus Systems GmbH); grants (Bayer HealthCare, Biogen Idec, European Union, Merck, Novartis, Roche Research Foundation, Swiss MS Society, Swiss National Research Foundation). Till Sprenger: has received no personal compensation. His previous and current institutions have received payments for research, for consulting and speaking activities from: Actelion, ATI, Biogen Idec, Electrocore, Sanofi Genzyme, Mitsubishi Pharma, Teva, Novartis; grants received (EFIC-Grünenthal, Novartis Pharmaceuticals Switzerland, Swiss MS Society, Swiss National Research Foundation).